Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

Karsten M. Strauss, L. Miguel Martins, Helene Plun-Favreau, Frank P. Marx, Sabine Kautzmann, Daniela Berg, Thomas Gasser, Zbginiew Wszolek, Thomas Müller, Antje Bornemann, Hartwig Wolburg, Julian Downward, Olaf Riess, Jörg B. Schulz*, Rejko Krüger

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

493 Citations (Scopus)


Recently targeted disruption of Omi/HtrA2 has been found to cause neurodegeneration and a parkinsonian phenotype in mice. Using a candidate gene approach, we performed a mutation screening of the Omi/HtrA2 gene in German Parkinson's disease (PD) patients. In four patients, we identified a novel heterozygous G399S mutation, which was absent in healthy controls. Moreover, we identified a novel A141S polymorphism that was associated with PD (P <0.05). Both mutations resulted in defective activation of the protease activity of Omi/HtrA2. Immunohistochemistry and functional analysis in stably transfected cells revealed that S399 mutant Omi/HtrA2 and to a lesser extent, the risk allele of the A141S polymorphism induced mitochondrial dysfunction associated with altered mitochondrial morphology. Cells overexpressing S399 mutant Omi/HtrA2 were more susceptible to stress-induced cell death than wild-type. On the basis of functional genomics, our results provide a novel link between mitochondrial dysfunction and neurodegeneration in PD.

Original languageEnglish
Pages (from-to)2099-2111
Number of pages13
JournalHuman Molecular Genetics
Issue number15
Publication statusPublished - 1 Aug 2005
Externally publishedYes


Dive into the research topics of 'Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease'. Together they form a unique fingerprint.

Cite this